Meet the Team
Meet Some of the Global 80+ Professionals that Make LS Law Possible
Marisa D
![Marisa D](/_gatsby/image/6f187e7f2ef4519e803e89e4d72d878d/f1ed88f4f36e35d61f5e14cf088130ff/CV_MarisaDreyer_Compliance_2022-1.jpg?u=https%3A%2F%2Flslaw.harryray.co.uk%2Fwp-content%2Fuploads%2F2022%2F12%2FCV_MarisaDreyer_Compliance_2022-1.jpg&a=w%3D75%26h%3D75%26fm%3Djpg%26q%3D75&cd=db045c31e9b806e786af73dcbeafa47a)
Ethics & Compliance Director (Swiss Office)
Overview of Experience
I manage the Swiss healthcare compliance arm of Life Science Law. Based in Zug, I have over 10 years of experience working within the pharmaceutical industry as a leading several compliance projects and transparency reporting expert.
My experience includes the development of compliance strategies and culture, compliance program roll-out, risk assessments, training and polices, along with monitoring, audit and investigations, and the EFPIA reporting requirements.
Areas of Expertise
I am a pharmaceutical compliance professional. My areas of expertise within the industry includes:
- The development and execution of compliance programs (Values and Company culture, FMV, ESG, Speak up, etc).
- The management of risk, to include risk analysis, remediation, and monitoring.
- The roll out of compliance management tools.
- Fair Market Value rates.
- EFPIA Disclosure requirements and emerging countries.
- Trainings: creation, development, and roll out.
- Project management E2E process expert (Transparency, CRM, Contract tool, CMS, Culture, and development, Speak up, Whistleblower, procurement, supply chain, Financial).
- Speak up and Whistleblower project development and implementation.
Regulatory Bodies of Expertise
Global and local regulatory pharmaceutical Codes of practice, including EFPIA, GPRD.
Track Record
At present, I manage the E2E automation process for the EFPIA Transparency Reporting obligations for a multi-national pharmaceutical company covering the UK, Germany, Switzerland, Austria, Italy, Greece, Malta, Cyprus, Luxembourg and Belgium, Nordics, starting a new approach on emerging countries: Brazil, Argentina, Colombia and Venezuela.
I am also managing the role out of a new automated transparency reporting platform to simplify the publication in Spain, Portugal and France, and developing a new process for the payment to Patient Organizations, and Fair Market Value monitoring (FMV).